Beta-Blockers and Coronary Flow Reserve

QR Code

Beta-Blockers and Coronary Flow Reserve

None

Saved in:

Bibliographic Details
Main Author:	Galderisi, Maurizio
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21612
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Transthoracic Echocardiography in Visualization of the Coronary Arteries and Assessment of Coronary Flow Reserve
by: Baghdady, Yasser, et al.
Published: (2012)

Ivabradine Versus Beta-Blockers in Patients with Conduction Abnormalities or Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting
by: Iliuta, Luminita, et al.
Published: (2012)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Beta-blockers. What about goes unsaid?
by: I. A. Latfullin
Published: (2008-10-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

The Role of TGF-β and TGF-β Receptors in Atherosclerosis
by: Nachtigal, Petr, et al.
Published: (2012)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016-01-01)

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol
by: N. L. Afanasyeva, et al.
Published: (2005-02-01)

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose
by: Varun Roperia MD, et al.
Published: (2025-07-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
by: A. G. Arutyunov, et al.
Published: (2022-01-01)

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker
by: Yap, Jayson, et al.
Published: (2012)

Pancreatic Beta Cell Tumors
by: Olmo, M. Isabel del, et al.
Published: (2011)

Imaging the Pancreatic Beta Cell
by: Ahlgren, Ulf, et al.
Published: (2011)

Beta Cell Replacement Therapy
by: SoRelle, Jeffrey A., et al.
Published: (2011)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
by: R. I. Striuk, et al.
Published: (2015-12-01)

USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?
by: V. V. Samoylenko, et al.
Published: (2015-09-01)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome
by: A. Yu. Proshlyakov, et al.
Published: (2021-07-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01)

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
by: A. O. Konradi, et al.
Published: (2018-12-01)

Effectiveness of beta-blockers in the treatment of idiopathic premature ventricular contractions in children
by: K. B. Alekseeva, et al.
Published: (2022-08-01)

Сardioprotective agents with biaromatic structure. Part 6. Beta blockers
by: G. V. Mokrov
Published: (2023-11-01)

Human Ovarian Tissue Cryopreservation as Fertility Reserve
by: Albani, Elena, et al.
Published: (2012)

Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy
by: Dogan Erdogan, et al.
Published: (2010-10-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2022-07-01)

Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
by: Santos, Cecília R A, et al.
Published: (2011)

Beta-Cell Function and Failure in Type 1 Diabetes
by: Vega-Monroy, Maria-Luisa Lazo de la, et al.
Published: (2011)

Structural and Computational Studies of Interactions of Metals with Amyloid Beta
by: Epa, V. Chandana
Published: (2012)

Altered cardiac‐coronary coupling relates to abnormal fractional flow reserve without flow limitation after percutaneous coronary interventions
by: Ahmet Tas, et al.
Published: (2025-07-01)

Is cardiac autonomic modulation influenced by beta blockers in adolescents with Duchenne Muscular Dystrophy?
by: Silva-Magalhães Talita Dias da, et al.
Published: (2025-07-01)

Beta Blockers as Primary and Secondary Prevention for Aortic Dissections in Nonsyndromic Patients With Hypertension
by: Mads Liisberg, et al.
Published: (2025-06-01)

THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression
by: О. D. Ostroumova, et al.
Published: (2018-09-01)

Dual L/N-Type Ca2+ Channel Blocker: Cilnidipine as a New Type of Antihypertensive Drug
by: Takahara, Akira
Published: (2012)

Dosimetry for Beta-Emitter Radionuclides by Means of Monte Carlo Simulations
by: Pérez, Pedro, et al.
Published: (2011)